Efficacy and safety of Janus Kinase Inhibitors versus Traditional DMARDs in moderate to severe Rheumatoid Arthritis. Acervo Científico [Internet]. 2025 Jun. 26 [cited 2026 Nov. 3];25:e20772. Available from: https://acervomais.com.br/cientifico/article/view/20772